Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy.
Reimann H, Kremer AN, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, Kämpf A, Rösler W, Kharboutli S, Mougiakakos D, Lang V, Lischer C, Irrgang P, Leppkes M, Gonzalez JV, Krönke G, Kremer AE, Tenbusch M, Bruns H, Harrer T, Müller F, Schett G, Mackensen A, Subklewe M, Völkl S. Reimann H, et al. Among authors: tenbusch m. Blood Adv. 2023 May 23;7(10):2066-2069. doi: 10.1182/bloodadvances.2022007806. Blood Adv. 2023. PMID: 36206194 Free PMC article. No abstract available.
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.
Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss MM, Heppt F, Meder C, Atreya R, Klenske E, Dietrich P, Abdullah A, Kliem T, Corte G, Morf H, Leppkes M, Kremer AE, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Maier C, Hueber AJ, Manger K, Manger B, Berking C, Tenbusch M, Überla K, Sticherling M, Neurath MF, Schett G. Simon D, et al. Among authors: tenbusch m. Nat Commun. 2020 Jul 24;11(1):3774. doi: 10.1038/s41467-020-17703-6. Nat Commun. 2020. PMID: 32709909 Free PMC article.
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2.
Lapuente D, Maier C, Irrgang P, Hübner J, Peter AS, Hoffmann M, Ensser A, Ziegler K, Winkler TH, Birkholz T, Kremer AE, Steininger P, Korn K, Neipel F, Überla K, Tenbusch M. Lapuente D, et al. Among authors: tenbusch m. Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):751-759. doi: 10.1007/s10096-020-04072-7. Epub 2020 Oct 20. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33078221 Free PMC article.
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections.
Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, Podolska MJ, Kouhestani D, David P, Birkholz T, Castellanos I, Trufa D, Sirbu H, Vetter M, Kremer AE, Hildner K, Hecker A, Edinger F, Tenbusch M, Mühl-Zürbes P, Steinkasserer A, Richter E, Streeck H, Berger MM, Brenner T, Weigand MA, Swirski FK, Schett G, Grützmann R, Weber GF. Bénard A, et al. Among authors: tenbusch m. Nat Commun. 2021 Feb 18;12(1):1112. doi: 10.1038/s41467-021-21310-4. Nat Commun. 2021. PMID: 33602937 Free PMC article.
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection.
Spoerl S, Kremer AN, Aigner M, Eisenhauer N, Koch P, Meretuk L, Löffler P, Tenbusch M, Maier C, Überla K, Heinzerling L, Frey B, Lutzny-Geier G, Winkler TH, Krönke G, Vetter M, Bruns H, Neurath MF, Mackensen A, Kremer AE, Völkl S. Spoerl S, et al. Among authors: tenbusch m. Eur J Immunol. 2021 Jun;51(6):1436-1448. doi: 10.1002/eji.202049135. Epub 2021 Apr 19. Eur J Immunol. 2021. PMID: 33784417 Free PMC article. Clinical Trial.
SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
Schmidt KG, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, Spriewald B, Bergmann S, Harrer EG, Harrer T. Schmidt KG, et al. Among authors: tenbusch m. Front Immunol. 2021 Apr 28;12:627568. doi: 10.3389/fimmu.2021.627568. eCollection 2021. Front Immunol. 2021. PMID: 33995351 Free PMC article. Clinical Trial.
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T, Steininger P, Irrgang P, Korn K, Tenbusch M, Diesch K, Achenbach S, Kremer AE, Werblow M, Vetter M, Bogdan C, Held J. Huber T, et al. Among authors: tenbusch m. Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1983-1997. doi: 10.1007/s10096-021-04285-4. Epub 2021 Jun 9. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34109500 Free PMC article.
Correction to: Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T, Steininger P, Irrgang P, Korn K, Tenbusch M, Diesch K, Achenbach S, Kremer AE, Werblow M, Vetter M, Bogdan C, Held J. Huber T, et al. Among authors: tenbusch m. Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1999-2004. doi: 10.1007/s10096-021-04301-7. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34269954 Free PMC article. No abstract available.
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity.
Kremer AE, Kremer AN, Willam C, Völkl S, Verhagen J, Achenbach S, van der Meijden ED, Lang V, Aigner M, Maier C, Tenbusch M, Korn K, Lutzny-Geier G, Spoerl S, Strauß R, Vetter M, Überla K, Neurath MF, Mackensen A, Schiffer M, Hackstein H. Kremer AE, et al. Among authors: tenbusch m. Eur J Immunol. 2021 Oct;51(10):2478-2484. doi: 10.1002/eji.202149277. Epub 2021 Sep 3. Eur J Immunol. 2021. PMID: 34350584 Free PMC article.
88 results